High-performance liquid chromatography has been used for measurement of the concentrations of total cysteine and cysteinylglycine in human urine. The method involved conversion of disulfides to their reduced counterparts by use of tris(2-carboxyethyl)phosphine hydrochloride, derivatization with 1-benzyl-2-chloropyridinium bromide, and ion-pairing reversed-phase high-performance liquid chromatographic separation with ultraviolet detection at 315 nm. The linearity of the method was validated in the ranges 50–300 and 5–50 µmol L−1 urine for cysteine and cysteinylglycine, respectively; regression coefficients were better than 0.999. The detection and quantitation limits were 0.2 and 0.5 µmol L−1, respectively, for both analytes. Intra-assay and inter-assay imprecision were below 6.0%, and accuracy was 98.95–100.80%. The method was applied to urine samples donated by apparently healthy volunteers.
[1]. A. Pastore R. Massoud C. Motti A. Lo Russo G. Fucci C. Cortese G. Federici 1998 Clin. Chem. 44 825.
[2]. K. Kuśmierek R. Głowacki E. Bald 2006 Anal. Bioanal. Chem. 385 855.
[3]. K. Kuśmierek E. Bald 2008 Chromatographia 67 23.
[4]. K. Kuśmierek G. Chwatko E. Bald 2008 Chromatographia 68 S91.
[5]. D.M. Townsend K.D. Kew H. Tapiero 2004 Biomed. Pharmacother. 58 47.
[6]. D. Joly P. Rieu A. Mejean M.F. Gagnadoux M. Daudon P. Jungers 1999 Pediatr. Nephrol. 13 945.
[7]. B. Rojkovich E. Nagy T. Prohle G. Poor P. Gergely 1999 Clin. Diagn. Lab. Immunol. 6 683.
[8]. A. Hernaz A. Plaza E. Martin-Mola E. DeMiguel 1999 Clin. Biochem. 32 65.
[9]. C. Zhao J. Zhang J. Song 2001 Anal. Biochem. 297 170.
[10]. P. Lochman T. Adam D. Friedecky E. Hlidkova Z. Skopkova 2003 Electrophoresis 24 1200.
[11]. M. Wroński 1996 J. Chromatogr. B 676 29.
[12]. U. Hannestad B. Sorbo 1979 Clin. Chim. Acta 95 189.
[13]. X. Huang T.W. Kok 1991 J. Liq. Chromatogr. 14 2207.
[14]. B. Kagedal M. Kallberg 1984 J. Chromatogr. B. 308 75.
[15]. T. Fiskerstrand H. Refsum G. Kvalheim P.M. Ueland 1993 Clin. Chem. 39 263.
[16]. P. Ventura R. Panini M.C. Pasini G. Scarpetta G. Savioli 1999 Pharmacol. Res. 40 345.
[17]. I. Fermo C. Arcelloni R. Paroni 2002 Anal. Biochem. 307 181.
[18]. S.C. Liang H. Wang Z.M. Zhang H.S. Zhang 2005 Anal. Bioanal. Chem. 381 1100.
[19]. E. Kaniowska G. Chwatko R. Głowacki P. Kubalczyk E. Bald 1998 J. Chromatogr. A 798 27.
[20]. E. Bald R. Głowacki J. Drzewoski 2001 J. Chromatogr. A 913 319.
[21]. K. Amarnath V. Amarnath K. Amarnath H.L. Valentine W.M. Valentine 2003 Talanta 60 1229.
[22]. M.J. Magera J.M. Lacey B. Casetta P. Rinaldo 1999 Clin. Chem. 45 1517.
[23]. J.E. Wear B.G. Keevil 2005 Clin. Chem. 51 787.
[24]. G. Weaving B.F. Rocks S.A. Iversen M.A. Titheradge 2006 Ann. Clin. Biochem. 43 474.
[25]. B. Seiwert U. Karst 2007 Anal. Chem. 79 7131.
[26]. E. Bald S. Sypniewski J. Drzewoski M. Stępień 1996 J. Chromatogr. B 681 283.
[27]. E. Bald S. Sypniewski 1997 Fresenius' J. Anal. Chem. 328 554.
[28]. V.P. Shah K.K. Midha S. Dighe I.J. McGilveray J.P. Skelly A. Yacobi T. Layloff C.T. Viswanathan C.E. Cook R.D. McDowall K.A. Pittman S. Spector 1992 Int. J. Pharm. 82 1.
[29]. FDA Guidance for Industry Bioanalytical Method Validation, http://www.fda.gov/cder/guidance/4252fnl.pdf.